Clinical Trial Update: Prognostic Value of Neonatal Markers for the Development of Neurosensorial Sequelae in Children Infected by Cytomegalovirus in Utero [NA]

View source ↗

Summary

A completed clinical trial assessing whether neonatal biomarkers can predict neurosensorial sequelae in children with congenital CMV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Cytomegalovirus Infection

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Congenital Cytomegalovirus Infection | NA | Status: COMPLETED